相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Steady-State Carbamazepine Pharmacokinetics Following Oral and Stable-Labeled Intravenous Administration in Epilepsy Patients: Effects of Race and Sex
S. E. Marino et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Safety of an IV formulation of carbamazepine
Jeannine M. Conway et al.
EPILEPSY RESEARCH (2009)
Sex Differences of Drug-metabolizing Enzyme: Female Predominant Expression of Human and Mouse Cytochrome P450 3A Isoforms
Tsutomu Sakuma et al.
JOURNAL OF HEALTH SCIENCE (2009)
The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial
Anthony G. Marson et al.
LANCET (2007)
Epilepsy in North America: A report prepared under the auspices of the Global Campaign against Epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization
William H. Theodore et al.
EPILEPSIA (2006)
Population pharmacokinetic modelling of carbamazepine in epileptic elderly patients: implications for dosage
I. B. Bondareva et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2006)
Pharmacological and clinical aspects of antiepileptic drug use in the elderly
E Perucca et al.
EPILEPSY RESEARCH (2006)
Epileptic seizures and epilepsy: Definitions proposed by the International League against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)
RS Fisher et al.
EPILEPSIA (2005)
The influence of age and sex on the clearance of cytochrome P450 3A substrates
MM Cotreau et al.
CLINICAL PHARMACOKINETICS (2005)
Serum carbamazepine concentrations in elderly patients: A case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data
D Battino et al.
EPILEPSIA (2003)
Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024
AF Ambrósio et al.
NEUROCHEMICAL RESEARCH (2002)
Common allelic variants of cytochrome P4503A4 and their prevalence in different populations
JK Lamba et al.
PHARMACOGENETICS (2002)
A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy
M Nieto-Barrera et al.
EPILEPSY RESEARCH (2001)
Population pharmacokinetics of free carbamazepine in adult Omani epileptic patients
D Deleu et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Population pharmacokinetics of carbamazepine in Singapore epileptic patients
E Chan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
P Kuehl et al.
NATURE GENETICS (2001)
Population pharmacokinetic modeling of steady state carbamazepine clearance in children, adolescents, and adults
DM Reith et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2001)
CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: Evidence for an allelic variant with altered catalytic activity
F Sata et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Age-related changes in protein binding of drugs - Implications for therapy
MK Grandison et al.
CLINICAL PHARMACOKINETICS (2000)
分享论文
